2342 — TransGenic Income Statement

0.000.00%

Last trade - 00:00

Consumer CyclicalsBalancedMicro CapValue Trap

Annual income statement for TransGenic, fiscal year end - March 31st, JPY millions except per share, conversion factor applied.

	2020 March 31st	2021 March 31st	2022 March 31st	2023 March 31st	2024 March 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Yuho	Yuho	Yuho	Yuho	Yuho
Standards:	JAS	JAS	JAS	JAS	JAS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	11,047	11,046	12,577	11,430	13,083
Cost of Revenue
Gross Profit	1,780	2,777	3,836	1,995	2,249
Selling / General / Administrative Expenses
Research And Development
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	11,276	10,373	11,264	12,027	13,056
Operating Profit	-230	674	1,312	-598	27.2
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	-250	695	2,768	-332	43.1
Provision for Income Taxes
Net Income After Taxes	-441	542	1,860	-440	3.99
Minority Interest
Net Income Before Extraordinary Items
Net Income	-441	546	1,876	-410	4.09
Adjustments to Net Income
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	-441	546	1,876	-410	4.08
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	-5.6	45	76.6	-0.013	5.69
Dividends per Share
Special Dividends per Share